
Our resources section is designed to be a toolkit supporting every step of your healthcare journey.
Prof. Christos Zouboulis and Dr Axel Villani kick-off the webinar series by explaining the fundamentals of the HS disease story and pathophysiology
Accompany Dr William Tillett and Dr Fabian Proft as they explore the approaches and challenges of managing D2T patients with PsA.
Achieving MDA or DAPSA treatment targets improves quality of life for patients with PsA.1–4 Explore the characteristics of patients who report treatment success...
ASDAS and BASDAI are commonly used in clinical practice.1,2 However, discover recent studies demonstrating that a high proportion of real-world patients do not...
Explore which treatment targets may be more appropriate for making treatment decisions in axSpA.
PsA and axSpA have overlapping disease manifestations which are driven by inflammation.1 Explore several extracellular cytokines that are implicated in these...
EU-DA-2300319
Date of preparation: November 2023